Medical News
Prevalence and Outcomes of Previously Healthy Adults Among P...
Chest.
The vast majority of patients hospitalized with community-onset sepsis have pre-existing comorbidities. However,...
21 Jan 2022
Bedside Risk Prediction for Positive Follow-Up Blood Culture...
Infection.
FUBCs may not need to be routinely used for patients with GNB bacteremia, and bedside risk predictors could be...
21 Jan 2022
Evaluation of Early Clinical Failure Criteria in Enterococcu...
Infection.
ECFC had good discrimination in predicting 28-day mortality in patients with Enterococcus species BSI. These...
20 Jan 2022
Development and Validation of BLOOMY Prediction Scores for 1...
Lancet Infect Dis.
The BLOOMY scores showed good discrimination and predictive values and could support the development of protocols...
20 Jan 2022
eCMEs
Key Trials
REGEN-COV Prevents COVID-19 Infection in Previously Uninfected Household Contacts of Infected Subjects
A single subcutaneous REGEN-COV injection prevented symptomatic Covid-19 and asymptomatic SARS-CoV-2 infection in previously uninfected household...
Pharmacokinetics and Pharmacodynamics of Imipenem by Two-Step and Extended Infusions in Sepsis Patients
The pharmacokinetic/pharmacodynamic (PK/PD) parameters achieved in two-step and extended regimens of imipenem were comparable in the treatment of...
Benefits of Inhaled Budesonide in Early COVID-19 Infection: STOIC Study
This infographic summarises the key points of the STOIC study and outlines the benefits of administering inhaled budesonide in early COVID-19...
Utility of C-Reactive Protein Based Protocol in the Duration of Antibiotic Therapy in Critically Ill Patients
A protocol based on daily monitoring of C-reactive protein levels may allow early interruption of antibiotic therapy in a higher proportion of...
Slide Library
Cefuroxime (Novacef)
Cefuroxime is a second-generation cephalosporin antibiotic. It is a broad-spectrum antibacterial agent with a favorable pharmacokinetic profile....
Management of Mucormycosis in ENT Practice
Mucormycosis are the group of invasive infection caused by filamentous fungi of the Mucoraceae family. This slide set enumerates prevalence,...
Antifungal Therapy in Immunocompromised Patients
Early initiation of antifungal therapy is a major contributor to enhanced survival rate. This set of slides highlights incidence and risk factors of...
Disseminated Tuberculosis with ARDS
Disseminated TB results from widespread blood borne dissemination of TB bacilli. This presentation includes causes and risk factors of disseminated...
Our Publications
Cipmolnu (Molnupiravir) Monograph
This monograph overviews in-vitro/clinical evidence for Molnupiravir efficacy, safety and positioning.
Molnupiravir: Fact Sheet for Healthcare Givers and Recipients
This fact sheet contains the factual details about the drug molnupiravir, its restricted use under emergency situation, dosage, side effects etc....
Molnupiravir - FAQ Booklet
This document addresses frequently asked questions related to oral antiviral drug Molnupiravir in the treatment of Covid-19.
Ronapreve (Casirivimab and Imdevimab) Monograph
Casirivimab and imdevimab are human, non-competing, high-affinity, IgG1 (immunoglobulin G1)-neutralising monoclonal antibodies produced by...
Poll
Do you perceive any clinical benefits of neurotrophic agent in the management of acute brain injury?
Yes
Sometimes
No
Total votes: 13